INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/24/2022
Back to search
Official data from USPTO
SEIKAGAKU
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
68
Latest update
10/24/2022
Trademark type
Combined
Nice classes
1, 5, 10
Filing date
03/13/2009
Registration date
06/28/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2021
Last transaction
12/22/2021
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Tokyo, JP
Examiner
DELGIZZI, RONALD
Law office
L70
Mark description
The mark consists of the literal element "SEIKAGAKU" and a design consisting of two oblong intersections shapes canted to the right and in the form of capsules.
Holders and representatives
Holders
S. C. (pessoa física)
S. C. (pessoa física)
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
(( Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparationscosmetic preparationsfoodnutritional supplements and biomaterialstissue-engineered productsartificial skin productsartificial vitreous body products and anti-adhesive productsfor research purposes in the biomedical field; )) Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of (( pharmaceutical preparationscosmetic preparationsfoodnutritional supplements and biomaterialstissue-engineered products)) artificial skin products and corneal preservation mediumfor research purposes in the biomedical field; Chemical reagents for scientificresearch and quality control purposeslimulus amebocyte lysate reagents for use in analysis of endotoxins (( and beta-glucan; Reagentsglycobiological analysis reagents for clinical and medical laboratory usediagnostic preparations and reagents for clinical and medical laboratory use ))
Class 5
(( Joint function improving agentspharmaceutical preparations for treating arthrosis and other joint diseases; Ophthalmic surgical aidsodium hyaluronate solution used for surgery in and around the eyes; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with pharmaceuticalscrosslinked or non-crosslinked hyaluronic acid based gel for the treatment of arthrosis and osteoarthritis; Syringes sold filled with pharmaceuticalssodium hyaluronate solutions for the treatment of arthrosis and osteoarthritis )) ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposesdiagnostic reagents for in-vitro clinical diagnostic purposes
Class 10
Injection syringes ; Injection needles
Publications
History of USPTO decisions and trademark events.
68 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/26/2022
INPC
INVALIDATION PROCESSED
09/26/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/22/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/22/2021
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/22/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
06/16/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/28/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/28/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/13/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/08/2018
INPC
INVALIDATION PROCESSED
03/08/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/26/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/26/2017
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
06/26/2017
71AG
REGISTERED-SEC.71 ACCEPTED
06/26/2017
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
06/26/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2017
71AF
REGISTERED-SEC.71 FILED
05/23/2017
15AF
REGISTERED - SEC. 15 AFFIDAVIT FILED
05/23/2017
ES71
TEAS SECTION 71 RECEIVED
05/23/2017
E15R
TEAS SECTION 15 RECEIVED
05/23/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/15/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/03/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/02/2011
FIMP
FINAL DISPOSITION PROCESSED
12/01/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/28/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/16/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2011
PUBO
PUBLISHED FOR OPPOSITION
04/12/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/24/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/24/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/05/2011
ALIE
ASSIGNED TO LIE
03/05/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/28/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/13/2011
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/13/2011
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
12/08/2010
GPRA
PRIORITY ACTION E-MAILED
12/08/2010
CPRA
PRIORITY ACTION WRITTEN
12/08/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/26/2010
GNRT
NON-FINAL ACTION E-MAILED
03/26/2010
CNRT
NON-FINAL ACTION WRITTEN
03/26/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2010
ALIE
ASSIGNED TO LIE
03/01/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/27/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/17/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/17/2010
RFNT
REFUSAL PROCESSED BY IB
09/29/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/27/2009
RFRR
REFUSAL PROCESSED BY MPU
08/27/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/25/2009
CNRT
NON-FINAL ACTION WRITTEN
08/24/2009
MAFR
APPLICATION FILING RECEIPT MAILED
08/18/2009
DOCK
ASSIGNED TO EXAMINER
08/14/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/13/2009
Continuous trademark protection
Get notified about every new filing that threatens SEIKAGAKU or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.